EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	36.76B
Revenue (ttm)	8.03B
Net Income (ttm)	1.94B
Shares Out	685.26M
EPS (ttm)	2.83
PE Ratio	18.95
Forward PE	n/a
Dividend	1.75 (3.26%)
Ex-Dividend Date	May 14, 2025

Volume	6,506,880
Average Volume	5,740,106
Open	54.40
Previous Close	53.65
Day's Range	52.70 - 54.85
52-Week Range	37.20 - 55.90
Beta	0.05
RSI	67.55
Earnings Date	Aug 5, 2025

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing. Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management. The company was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,088
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2024, IST:ECILC's revenue was 8.77 billion, a decrease of -6.28% compared to the previous year's 9.36 billion. Earnings were 1.02 billion, a decrease of -74.12%.